- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02388542
Effect of Peer-mentor Mediated Interventions on Cardiovascular Risk Factors at Worksites (PROGRESS)
Policy and Peer Mentor Intervention Programs on Cardiovascular Disease at Small to Medium Sized Worksites in 3 South Asian Countries - a Pilot Study for a Definitive Large International Cluster Randomized Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Eligibility Criteria -
All employees aged above 35 years at selected workplaces.
Study design - Mixed methods methods Phase 1 - Qualitative study; Phase 2 - Quantitative - Single group, non-randomized before-after comparison study + KAP survey
Sample size - Approximately 334 participants.
The study entails the following steps -
Step 1 - An evaluation for knowledge, attitudes and practices (KAP) related to cardiovascular health/ disease at worksites.
Step 2 - A qualitative study for barriers and facilitators of behaviors associated with optimal cardiovascular health
Step 3 - Baseline assessment of cardiovascular risk using a non-lab based risk assessment score
Step 4 - Piloting a trained peer mentored educational/ intensive follow-up intervention for 3 month with a re-assessment at 3 months.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Dhaka, Bangladesh
- Appollo Ispat Complex Ltd
-
Dhaka, Bangladesh
- Shardharan Bima Coorporation
-
-
-
-
-
Bangalore, India
- Bharat Heavy Electrical Limited
-
Hosur, India
- TVS Motor company Limited
-
-
-
-
-
Colombo, Sri Lanka
- Department of Census & Statistics
-
Colombo, Sri Lanka
- Sri Lanka Telecom
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
All criteria must be met to be eligible
- Employees (Men & Women) above the age of 35 years.
- permanent employees with at least 6 months for retirement.
- Willing to provide Informed Consent.
Exclusion Criteria:
Subject ineligible if even one criterion is met
- Pregnant or intent to get pregnant in one year.
- Inability to attend follow up visits.
- Any active malignancy or known malignancy on treatment.
- Will relocate during the study period.
- Unwilling or unable to comply with study procedures.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: lifestyle counseling
we will have a trained peer mentor educating employees regarding lifestyle modification for control of cardiovascular disease risk factors and following them up for a duration of 3 months
|
Employees above the age of 35 years will be risk stratified into moderate or high risk of developing cardiovascular disease using a simple non-lab based risk scoring system, they will be invited to participate in the pilot intervention study.
This is a single arm before-after study.subject
education will focus on life style medication and adherence to medication (if applicable).importantly
the peer mentor will try to identify barriers to adopting a healthy lifestyle(tobacco, physical acitivity, diet, alcohol and strees) and adherence to cardiovascular disease prevention medication.
peer mentors will be trained to interpret blood glucose and lipids, recognize abnormal valves, provide lifestyle counseling and refer to treating physician when appropriate.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in knowledge attitudes & practices related to Cardiovascular risk factors. (questionnaire)
Time Frame: 1 Month
|
A knowledge, attitudes & practices questionnaire will be administered to participants
|
1 Month
|
|
Identification of barriers and facilitators for an optimal Cardiovascular Health environment. (In depth interviews and focus groups discussions with random sample of participants)
Time Frame: 3 Months
|
qualitative analysis - In depth interviews and focus groups discussions with random sample of participants
|
3 Months
|
|
Estimate the Cardiovascular risk factor burden (validated non lab based Cardiovascular risk score)
Time Frame: 3 Months
|
validated non lab based Cardiovascular risk score will be used (developed from NHANES data and validated against Framingham score
|
3 Months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Dr Denis Xavier, M.D,MSc., St.John's Medical College
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PROGRESS-IND-1022015
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.